Regulation of Tumor Progression by Peroxisome Proliferator-Activated Receptor-gamma in Non-small Cell Lung Cancer
Agents that activate the PPARgamma protein have already been used in the treatment of diabetes and atherosclerosis. Dr. Keshamouni is researching whether and how they affect the growth of non-small cell lung cancer (NSCLC) cells.